INTERNATIONAL PATENT: IOVANCE BIOTHERAPEUTICS, INC. FILES APPLICATION FOR "ENGINEERED ARTIFICIAL ANTIGEN PRESENTING CELLS AND LIPID NANOPARTICLES FOR TUMOR INFILTRATING LYMPHOCYTE EXPANSION"

GENEVA, March 11 -- IOVANCE BIOTHERAPEUTICS, INC. (825 Industrial RoadSuite 100San Carlos, California 94070) filed a patent application (PCT/US2025/043475) for "ENGINEERED ARTIFICIAL ANTIGEN PRESENTING CELLS AND LIPID NANOPARTICLES FOR TUMOR INFILTRATING LYMPHOCYTE EXPANSION" on Aug 26, 2025. With publication no. WO/2026/050217, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HASIPEK, Metis (c/o Iovance Biotherapeutics, Inc.825 Industrial Road, Suite 100San Carlos, California 94070), HALL, Sean (c/o Iovance Biotherapeutic...